Leadership Overview
Promega has 6 executives leading key functions including strategy, finance, information technology, revenue, medical affairs, and general management.
Focused on advancing biotechnology through innovation, Promega delivers essential tools for genomics and drug discovery while maintaining a commitment to scientific excellence and global molecular biology research.
Focused on advancing biotechnology through innovation, Promega delivers essential tools for genomics and drug discovery while maintaining a commitment to scientific excellence and global molecular biology research.
Leadership Roles at Promega
William Linton - Chairman, Chief Executive Officer & President
William Linton, the Chairman, Chief Executive Officer & President at Promega, directs the overarching corporate strategy for this biotechnology manufacturer. Overseeing the development of enzymes and molecular biology products, the Chairman, Chief Executive Officer & President ensures alignment across genomics and drug discovery portfolios. This leadership role involves guiding long-term research investments to maintain market dominance in cellular analysis. By fostering a culture of scientific inquiry, William Linton drives the organization toward sustainable growth and technological advancement. The Chairman, Chief Executive Officer & President manages high-level interactions with the board to secure operational stability. Through consistent focus on innovation, Linton shapes the trajectory of the company within the global life sciences sector, ensuring that the product pipeline meets the evolving needs of researchers worldwide while upholding the rigorous standards expected of a leader in the biotechnology industry.
Chris Yarbro - Chief Financial Officer
Chris Yarbro, the Chief Financial Officer at Promega, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning and analysis, the Chief Financial Officer ensures that resources support the manufacturing of enzymes and protein analysis tools. This leadership role involves optimizing budgetary frameworks to facilitate expansion in the genomics and cellular analysis markets. By monitoring global economic trends, Chris Yarbro mitigates financial risks while supporting the strategic objectives of the executive team. The Chief Financial Officer maintains rigorous oversight of corporate expenditures to ensure efficiency across all manufacturing facilities. Through precise financial modeling and reporting, Yarbro provides the necessary data to inform critical business decisions. This role remains essential for maintaining the financial integrity of the company as the organization scales operations to meet the increasing demand for molecular biology solutions across international markets.
Kristen Yetter - General Manager and President
Kristen Yetter, the General Manager and President at Promega, executes the operational strategy and day-to-day management of the company's core business units. Overseeing the manufacturing and distribution of enzymes and cellular analysis products, the General Manager and President ensures that production targets meet the demands of the global biotechnology market. This leadership role involves streamlining internal processes to enhance productivity and quality control. By managing cross-departmental workflows, Kristen Yetter maintains operational excellence across the organization. The General Manager and President works closely with the executive team to implement policies that support the company's mission of advancing molecular biology. Through effective resource management, Yetter drives efficiency in the supply chain and manufacturing operations. This role remains vital for ensuring that the company delivers high-quality products to researchers and clinicians, thereby supporting the overall growth and stability of the business in a competitive industry.
Brian Schiro - Chief Information Officer
Brian Schiro, the Chief Information Officer at Promega, architects the digital infrastructure required to support complex biotechnology manufacturing processes. Overseeing enterprise systems and data security, the Chief Information Officer ensures that information flows seamlessly across genomics and drug discovery departments. This leadership role involves implementing advanced analytics to improve operational efficiency and product development cycles. By modernizing the technological landscape, Brian Schiro enables the company to maintain a competitive edge in the molecular biology sector. The Chief Information Officer collaborates with other executives to integrate digital solutions that enhance research capabilities and supply chain transparency. Through the deployment of scalable cloud platforms, Schiro supports the global reach of the organization. This role remains vital for protecting intellectual property and ensuring that data-driven insights continue to fuel the scientific advancements that define the company's market position.
Kara Machleidt - Global Chief Revenue Officer, Strategic Business Lead
Kara Machleidt, the Global Chief Revenue Officer, Strategic Business Lead at Promega, directs the commercial strategy and market expansion efforts for the biotechnology portfolio. Overseeing revenue generation across genomics and protein analysis, the Global Chief Revenue Officer, Strategic Business Lead ensures that sales initiatives align with the specific needs of the drug discovery and genetic identity markets. This leadership role involves identifying new growth opportunities and strengthening relationships with key research institutions. By optimizing the sales funnel, Kara Machleidt drives consistent revenue growth while expanding the company's footprint in international territories. The Global Chief Revenue Officer, Strategic Business Lead coordinates with cross-functional teams to deliver value-added solutions to clients. Through strategic market positioning, Machleidt secures long-term partnerships that reinforce the company's status as a leader in molecular biology. This role remains critical for translating scientific innovation into tangible commercial success on a global scale.
Ash Anderson - Chief Medical Officer
Ash Anderson, the Chief Medical Officer at Promega, provides clinical oversight and scientific guidance for the development of diagnostic and molecular biology products. Overseeing medical affairs, the Chief Medical Officer ensures that all product applications meet the highest standards of clinical relevance and regulatory compliance. This leadership role involves bridging the gap between laboratory research and practical medical application in fields such as genetic identity and drug discovery. By evaluating clinical data, Ash Anderson informs the strategic direction of the product pipeline. The Chief Medical Officer collaborates with internal research teams to validate the efficacy of new biotechnology tools. Through rigorous scientific review, Anderson ensures that the company's offerings address critical challenges in the healthcare and research sectors. This role remains essential for maintaining the credibility and scientific integrity of the organization as the company continues to innovate within the complex landscape of molecular diagnostics.
Explore Leadership Teams in Manufacturing
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership CD
NB
ES
SS
Hetero is a global pharmaceutical company founded in 1993 and headquartered in India with operations across Asia, Europe, North America, South America, Africa, and the Middle East. The company specializes in manufacturing generic pharmaceuticals and is recognized as a major producer of anti-retroviral medications for HIV/AIDS treatment. Hetero develops and manufactures a wide range of pharmaceutical products while maintaining research facilities and production centers worldwide.
Company Leadership RS
KS
VS
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership
BM
LB
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership NY
DR
SD
Frequently Asked Questions Regarding Promega Top Executives and Leadership Team
Unlock more people and company data
